Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Hepatology (Baltimore, Md.)|May 13, 2022
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLDEkaterina Smirnova, Mark D Muthiah, Nicole Narayan, et al.Hepatology (Baltimore, Md.)|January 21, 2019
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing CholangitisMichael Trauner, Aliya Gulamhusein, Bilal Hameed, et al.Cell Reports|November 2, 2022
Arid1a loss potentiates pancreatic β-cell regeneration through activation of EGF signalingCemre Celen, Jen-Chieh Chuang, Shunli Shen, et al.Hepatology (Baltimore, Md.)|June 10, 2022
IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASHJun Xu, Ya Wang, Mina Khoshdeli, et al.Cell Stem Cell|April 6, 2016
Suppression of the SWI/SNF Component Arid1a Promotes Mammalian RegenerationXuxu Sun, Jen-Chieh Chuang, Mohammed Kanchwala, et al.Elife|July 12, 2017
<i>Arid1b</i> haploinsufficient mice reveal neuropsychiatric phenotypes and reversible causes of growth impairmentCemre Celen, Jen-Chieh Chuang, Xin Luo, et al.Cell Metabolism|April 9, 2010
Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertilityJennifer W Hill, Carol F Elias, Makoto Fukuda, et al.Cancer Cell|November 15, 2017
Arid1a Has Context-Dependent Oncogenic and Tumor Suppressor Functions in Liver CancerXuxu Sun, Sam C Wang, Yonglong Wei, et al.Hepatology (Baltimore, Md.)|November 10, 2020
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASHRohit Loomba, Mazen Noureddin, Kris V Kowdley, et al.Pageof 5